Publication: Erectile Dysfunction in Heme-Deficient Nitric Oxide–Unresponsive Soluble Guanylate Cyclase Knock-In Mice
No Thumbnail Available
Open/View Files
Date
2017
Published Version
Journal Title
Journal ISSN
Volume Title
Publisher
Elsevier BV
The Harvard community has made this article openly available. Please share how this access benefits you.
Citation
Decaluwé, Kelly, Bart Pauwels, Charlotte Boydens, Robrecht Thoonen, Emmanuel S. Buys, Peter Brouckaert, and Johan Van de Voorde. 2017. “Erectile Dysfunction in Heme-Deficient Nitric Oxide–Unresponsive Soluble Guanylate Cyclase Knock-In Mice.” The Journal of Sexual Medicine 14 (2) (February): 196–204. doi:10.1016/j.jsxm.2016.12.007.
Research Data
Abstract
Introduction: The nitric oxide (NO), soluble guanylate cyclase (sGC), and cyclic guanosine monophosphate (cGMP) pathway is the leading pathway in penile erection. Aim: To assess erectile function in a mouse model in which sGC is deficient in heme (apo-sGC) and unresponsive to NO. Methods: Mutant mice (sGCb1 ki/ki) that express an sGC enzyme that retains basal activity but fails to respond to NO because of heme deficiency (apo-sGC) were used. Isolated corpora cavernosa from sGCb1 ki/ki and wild-type mice were mounted in vitro for isometric tension recordings in response to sGC-dependent and -independent vasorelaxant agents. In addition, the erectile effects of some of these agents were tested in vivo at intracavernosal injection. Main Outcome Measures: In vitro and in vivo recordings of erectile responses in sGCb1 ki/ki and wild-type mice after stimulation with sGC-dependent and -independent vasorelaxant agents. Results: NO-induced responses were abolished in sGCb1 ki/ki mice in vitro and in vivo. The ability of the heme-dependent, NO-independent sGC stimulator BAY 41-2272 to relax the corpora cavernosa was markedly attenuated in sGCb1 ki/ki mice. In contrast, the relaxation response to the heme- and NO-independent sGC activator BAY 58-2667 was significantly enhanced in sGCb1 ki/ki mice. The relaxing effect of sGC-independent vasorelaxant agents was similar in wild-type and sGCb1 ki/ki mice, illustrating that the observed alterations in vasorelaxation are limited to NO-sGC-cGMPemediated processes. Conclusion: Our results suggest that sGC is the sole target of NO in erectile physiology. Furthermore, this study provides indirect evidence that, in addition to sGCa1b1, sGCa2b1 is important for erectile function. In addition, the significant relaxation observed in sGCb1 ki/ki mice with the cumulative addition of the sGC activator BAY 58-2667 indicates that sGC activators might offer value in treating erectile dysfunction.
Description
Other Available Sources
Keywords
soluble guanylate cyclase, apo-sGC, erectile dysfunction, oxidative stress, soluble guanylate cyclase activators, soluble guanylate cyclase stimulators
Terms of Use
Metadata Only